Modeling and Simulation - PK/PD Archives | Page 7 of 44

On-Demand Webinar

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…

CertaraJune 18, 2025

On-Demand Webinar

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

CertaraJune 11, 2025

Publication

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…

CertaraJune 8, 2025

On-Demand Webinar

Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development

CertaraMay 21, 2025

Blog Knowledge Base

Extrapolating AUC to Infinity

AUC calculations are simple but nuanced. In this blog, we look at how to extrapolate…

CertaraMay 15, 2025

Blog Knowledge Base

Calculating AUC (Linear and Log-linear)

AUC calculations are simple but nuanced. In this blog, we look at how to calculate…

CertaraApril 2, 2025

Blog Knowledge Base

Accumulation: What It Means and How to Calculate It

In this blog, we look closely at drug accumulation ratio, to help you understand and…

CertaraApril 2, 2025

Video

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

CertaraMarch 27, 2025

Video

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

CertaraMarch 26, 2025

Video

Behind the Science: Meet Sr. Director Craig Comisar

CertaraMarch 26, 2025

Modeling and Simulation – PK/PD

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development

Extrapolating AUC to Infinity

Calculating AUC (Linear and Log-linear)

Accumulation: What It Means and How to Calculate It

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

Behind the Science: Meet Sr. Director Craig Comisar

Newsletter sign up

Quick links

Solutions

Contact